Lawyer profile
David McIntosh
Ropes & Gray
- Firm
- Ropes & Gray
- Practice
- IP transactions, life sciences licensing, life sciences transactions
- Office
- Not stated
- Active in the record
- 2022 to 2025
Deal experience
Deals
8 announced deals in the record Ropes & Gray Advises Matchpoint Therapeutics in Novartis Option and License Agreement Worth Up to $1 Billion 1 Aug 2025
Pro Bono Team Advises Global RDH12 Alliance and Eyes on the Future in Collaboration with Opus Genetics to Advance Gene Therapy for Inherited Childhood Blindness 1 Aug 2025
Ropes & Gray Advises Monte Rosa Therapeutics in Global Licensing Collaboration with Novartis 7 Nov 2024
Ropes & Gray Advises Dessert Holdings in its Acquisition of Kenny’s Great Pies 17 May 2024
Ropes & Gray Advises MACOM in Completed Acquisition of Wolfspeed’s RF Business 7 Dec 2023
Ropes & Gray Represents ImmunoGen in its $10.1 Billion Sale to AbbVie 1 Dec 2023
Ropes & Gray Advises Avidity Biosciences in Expanded Cardiovascular Global Licensing Collaboration with Bristol Myers Squibb 1 Dec 2023
Ropes & Gray Advises Intrinsic Medicine in de-SPAC Business Combination Agreement with Phoenix Biotech Acquisition Corp. 31 Oct 2022
Deal alerts PRO
Get an email when David McIntosh is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile